Cabaletta Bio, Inc.

CABA

$3.48

-2.52%

N/A-$0.09

Healthcare

Biotechnology

NASDAQ

Active Trading

Cabaletta Bio, Inc. is a biotechnology firm in the clinical development stage, specializing in the invention and advancement of sophisticated engineered T ...

Supply Chain of CABA

Upstream / Downstream / Proxies

Upstream

CellaresLonza Group AGSIX:LONNMinaris Advanced Therapies (f/k/a WuXi Advanced Therapies)Oxford Biomedica plcLSE:OXBAutolus Therapeutics plcNASDAQ:AUTLUniversity of PennsylvaniaArtisan Bio, Inc.Thermo Fisher Scientific Inc.NYSE:TMO Bio-Techne Corporation (B-MoGen / R&D Systems)NASDAQ:TECH

Downstream

Academic Medical Centers (Clinical Trial Sites)Apheresis Collection Centers (Hospital Networks)Lupus Foundation of America (LFA)Myasthenia Gravis Foundation of America (MGFA)Cure JM FoundationLupus and Allied Diseases Association (LADA)

Proxies

Kyverna Therapeutics, Inc.NASDAQ:KYTX Fate Therapeutics, Inc.NASDAQ:FATE Caribou Biosciences, Inc.NASDAQ:CRBU Legend Biotech CorporationNASDAQ:LEGN CRISPR Therapeutics AGNASDAQ:CRSP

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer